Obese women with OSAS incurred significantly higher physician fees one year before diagnosis compared to obese controls ($547.49 vs $246.85, P<0.0001).
Observational (n=669)
No
Do obesity and sleep apnea increase health care expenditure in women over 10 years?
Obese women with OSAS have significantly higher healthcare utilization and costs in the 10 years prior to diagnosis compared to obese and normal-weight controls.
Absolute Event Rate: 547.49% vs 246.85%
p-value: p=<0.0001
STUDY OBJECTIVES: To determine the effect of obesity and sleep apnea on health care expenditure in women over 10 years. DESIGN: Retrospective observational study SETTING: Tertiary university-based medical center PATIENTS AND CONTROLS: Three groups of age-matched women: 223 obese women with OSAS (body mass index: 39. 3 +/- 0. 6 kg/m2), and from the general population, 223 obese controls (BMI 36. 3 +/- 0. 4) and 223 normal weight controls (BMI 23. 9 +/- 0. 4). INTERVENTIONS: None. MEASUREMENTS AND RESULTS: We examined health care utilization in the 3 matched groups for the 10 years leading up to the documentation of OSAS. The mean physician fees and the number of physician visits were significantly higher in obese controls than in normal weight controls during the observed period. Physician fees and physician visits progressively increased in the 10 years before diagnosis in the OSAS cases and were significantly higher than in the matched obese controls. Physician fees, in Canadian dollars, one year before diagnosis in the OSAS cases were higher than in obese controls: 547. 49 +/- 34. 79 vs 246. 85 +/- 20. 88 (P<0. 0001). More was spent for OSAS cases on physician fees for circulatory, endocrine and metabolic diseases, and mental disorders than the obese controls. Physician visits one year before diagnosis in the OSAS cases were more frequent than in the obese controls: 13. 2 +/- 0. 73 visits vs 7. 26 +/- 0. 49 visits (P<0. 0001). CONCLUSIONS: Obese women are heavier users of health services than normal weight controls. Obese women with OSAS use significantly more health services than obese controls. Since OSAS imposes a greater financial burden, treatment of OSAS may reduce other comorbidities and lower overall medical costs.
Banno et al. (Sun,) conducted a observational in Obesity and Obstructive Sleep Apnea Syndrome (OSAS) (n=669). Obese with OSAS vs. Obese controls and normal weight controls was evaluated on Physician fees one year before diagnosis (in Canadian dollars) (p=<0.0001). Obese women with OSAS incurred significantly higher physician fees one year before diagnosis compared to obese controls ($547.49 vs $246.85, P<0.0001).